The possible role of adrenergic component in ischemic preconditioning

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 7, 1997, Pages 493-499

  Sharma, Ajay ^a   Singh, Manjeet ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Arrhythmias; Myocardial infarction; Prazosin; Preconditioning; Reserpine

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; LACTATE DEHYDROGENASE; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; RESERPINE;

ADRENERGIC SYSTEM; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DOG; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HEMODYNAMIC PARAMETERS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BLOOD PRESSURE; CATECHOLAMINES; DOGS; ELECTROCARDIOGRAPHY; FEMALE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL INFARCTION; PRAZOSIN; RATS; REPERFUSION INJURY; RESERPINE;

EID: 0030733134     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Swam, J.L., Sabina, R.L., Hines, J.J., Greenfield, J.C., Holme, E.W. Repetitive episodes of brief ischemia (12 min) do not produce a cumulative depletion of high energy phosphate compounds. Cardiovasc Res 1984, 18: 264-9.
2. Reimer, K.A., Murry, C.E., Yamasawa, I., Hill, M.L., Jennings, R.B. Four brief periods of ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 1986, 251: H1306-15.
3. Murry, C.E., Jennings, R.B., Reimer, K.A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74: 1124-36.
4. Vegh, A., Szekcrcs, L., Parrat, J.R. Protective effects of preconditioning of the ischemic myocardium involve cycio-oxygenase products. Cardiovasc Res 1990, 24: 1020-3.
5. Shiki, K., Hearse, D.J. Preconditioning of ischemic myocardium: Reperfusion induced arrhythmias. Am J Physiol 1987, 253: H1470-6.
6. Toombs, C.F., Wiltes, A.L., Shebuski, R.J. Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium. Implication of norepinephrine release in the preconditioning effect. Circulation 1993, 88: 2351-8.
7. Thornton, J.D., Daly, J.F., Cohen, M.V., Yang, X., Downey, J.M. Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ Res 1993, 73: 649-55.
8. Kitakaze, T.M., Hori, M., Morioka, T, et al. α1-Adrenoceptor activation mediates infarct size-limiting effect of ischemic preconditioning through augmentation of 5-nucleotidase activity. J Clin Invest 1994, 93: 2197-205.
9. Sebbag, L., Katsugawa, M., Verhinski, S., Jennings, R.B., Reimer, K.A. Intracoronary administration of the α1-receptor agonist, methoxamine, does not reproduce the infarctlimiting effect of ischemic preconditioning in dogs. Cardiovase Res 1996, 32: 830-8.
10. Lie, J.T., Pairolero, P.C., Holley, K.E., Tilus, J.L. Macroscopic enzyme mapping verification of large homogenous experimental infarcts of predictable size and location in dogs. J Thorac Cardiovasc Surg 1975, 69: 599-606.
11. Fishbein, M.C., Meerbaum, S., Rit, J. et al. Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981, 101: 593-600.
12. Chopra, K., Singh, M., Kaul, L., Andrabi, K., Ganguly, N.K. Decrease of myocardial infarct size with desferrioxamine: Possible role of oxygen free radicals in its ameliorative effect. Mol Cell Biochem 1992, 113: 71-6.
13. Banka, N., Anand, I.S., Chakravarti, R.N., Sharma, P.L., Wahi, P.L. Macroscopic measurements of experimental myocardial infarct size in rhesus monkey. A comparison of two methods. Bull PGI 1981, 15: 147-50.
14. Langendorff, O. Untersuchungen am uberlebenden Saugethierherzen. Pflügers Arch Gesmate Physiol 1895, 61: 291-332.
15. King, J. A routine method for the estimation of lactic dehydrogenase activity. J Med Lab Tech 1959, 16: 265-72.
16. Cox, R.H. Jr., Perhach, J.L. Jr. A sensitive, rapid and simple method for the simultaneous spectrofluorometric determination of norepinephrine, dopamine, 5-hydroxytryptamine and 5-hydroxyindole acetic acid in discrete areas of brain. J Neurochem 1973, 20: 1777.
17. Richardt, G., Waas, W., Kranzboter, R., Maya, E., Schomig, A. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: A protective mechanism in early myocardial ischemia. Circ Res 1987, 61: 117-23.
18. Schomig, A., Dart, A.M., Dietz, R., Mayer, E., Kubler, W. Release of endogenous catechalamines in the ischemic myocardium of the rat heart. Part A. Locally mediated release. Circ Res 1984, 55: 689-701.
19. Bankwala, Z., Sharon, L.H., Kloner, R.A. α-Adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. Circulation 1994, 90: 1023-8.
20. Tsuchida, A., Liu, Y., Liu, G.S., Cohen, M.V., Downey, J.M. α1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994, 75: 576-85.
21. Vander Heide, R.S., Schwartz, L.M., Jennings, R.B., Reimer, K.A. Effect of catecholamine depletion on infarct size in dogs: Role of catecholamines in ischemic preconditioning. Cardiovasc Res 1995, 30: 656-67.
22. Bugge, E., Ytrehus, K. Ischemic preconditioning is protein kinase C dependent but not through stimulation of α-adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc Res 1995, 29: 401-6.
23. Tosaki, A., Behjet, N.S., Engelman, D.T., Engelman, R.M., Das, D.K. α1-Adrenergic receptor agonist-induced preconditioning in isolated working rat hearts. J Pharmacol Exp Ther 1995, 273: 689-94.